tetano
Editor, Senior Moderator
J Med Virol
. 2021 Dec 1.
doi: 10.1002/jmv.27483. Online ahead of print.
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients
Yufeng Shang[SUP] 1 [/SUP], Yuxing Liang[SUP] 1 [/SUP], Tao Liu[SUP] 2 3 [/SUP], Jingfeng Li[SUP] 4 [/SUP], Fuling Zhou[SUP] 1 [/SUP]
Affiliations
Abstract
The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Early detection and intervention are key factors for improving outcomes in patients with COVID-19. Real-time reverse transcriptase polymerase chain reaction-based molecular assays and antibody for detecting SARS-CoV-2 in respiratory specimens are the current reference standard for COVID-19 diagnosis. Clinical implications of different specimen types for nucleic acid and antibody testing of COVID-19 in Zhongnan hospital of Wuhan University were analyzed. Compared with health groups, tumor patients had higher rate of SARS-CoV-2 (+/-) IgM (+) IgG (+). The rate of SARS-CoV-2 (-) IgM (+) IgG (-) or SARS-CoV-2 (-) IgM (-) IgG (+) in female was significantly higher than that in male. These results can help governments to take screening measures to prevent the COVID-19 pandemic again. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Cancer; Female; SARS-CoV-2.
. 2021 Dec 1.
doi: 10.1002/jmv.27483. Online ahead of print.
Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients
Yufeng Shang[SUP] 1 [/SUP], Yuxing Liang[SUP] 1 [/SUP], Tao Liu[SUP] 2 3 [/SUP], Jingfeng Li[SUP] 4 [/SUP], Fuling Zhou[SUP] 1 [/SUP]
Affiliations
- PMID: 34850404
- DOI: 10.1002/jmv.27483
Abstract
The novel coronavirus disease 2019 (COVID-19) has become a global health emergency. Early detection and intervention are key factors for improving outcomes in patients with COVID-19. Real-time reverse transcriptase polymerase chain reaction-based molecular assays and antibody for detecting SARS-CoV-2 in respiratory specimens are the current reference standard for COVID-19 diagnosis. Clinical implications of different specimen types for nucleic acid and antibody testing of COVID-19 in Zhongnan hospital of Wuhan University were analyzed. Compared with health groups, tumor patients had higher rate of SARS-CoV-2 (+/-) IgM (+) IgG (+). The rate of SARS-CoV-2 (-) IgM (+) IgG (-) or SARS-CoV-2 (-) IgM (-) IgG (+) in female was significantly higher than that in male. These results can help governments to take screening measures to prevent the COVID-19 pandemic again. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Cancer; Female; SARS-CoV-2.